Long intergenic non-protein coding RNA 2963 (LINC02963)

Long intergenic non-protein coding RNA 2963 (LINC02963) is an autonomously transcribed long non-coding RNA gene in humans, annotated as ENSG00000255652 in Ensembl and 123706542 in NCBI Gene[5][1]. LINC02963 belongs to the class of long intergenic non-coding RNAs (lincRNAs), which are longer than 200 nucleotides and do not overlap protein-coding genes[3]. LincRNAs are believed to participate in regulatory processes such as chromatin remodeling, transcriptional regulation, and maintaining genome architecture, but while thousands have been annotated in the human genome, only a small subset have experimentally validated and functionally characterized roles[3]. LINC02963 itself has not been specifically described in literature as a protein-coding gene, therapeutic target, or disease biomarker, and no specific small-molecule or biological drugs are known to interact with this RNA as of current literature. Further research would be required to clarify any disease associations, biomarker relevance, or suitability as a drug target. Summary: Long intergenic non-protein coding RNA 2963 (LINC02963) is a human lincRNA gene, not a protein or classic drug target, with no established use in clinical biomarker panels or pharmacology[1][5][3]. It is part of the broader family of long intergenic non-coding RNAs, which are known to have regulatory roles in gene expression, although the exact function of LINC02963 remains uncharacterized. No therapeutic targeting, disease association, or safety information is available for this specific lincRNA.

Other names

lncRNA-p3134LINC02963